{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:24:50Z","timestamp":1790349890240,"version":"4.1.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005031","name":"DAE | Bhabha Atomic Research Centre","doi-asserted-by":"publisher","award":["37(1)\/14\/30\/2016-BRNS"],"award-info":[{"award-number":["37(1)\/14\/30\/2016-BRNS"]}],"id":[{"id":"10.13039\/501100005031","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The histone modifiers (HMs) are crucial for chromatin dynamics and gene expression; however, their dysregulated expression has been observed in various abnormalities including cancer. In this study, we have analyzed the expression of HMs in microarray profiles of head and neck cancer (HNC), wherein a highly significant overexpression of p21-activated kinase 2 (PAK2) was identified which was further validated in HNC patients. The elevated expression of PAK2 positively correlated with enhanced cell proliferation, aerobic glycolysis and chemoresistance and was associated with the poor clinical outcome of HNC patients. Further, dissection of molecular mechanism revealed an association of PAK2 with c-Myc and c-Myc-dependent PKM2 overexpression, wherein we showed that PAK2 upregulates c-Myc expression and c-Myc thereby binds to PKM promoter and induces PKM2 expression. We observed that PAK2\u2013c-Myc\u2013PKM2 axis is critical for oncogenic cellular proliferation. Depletion of PAK2 disturbs the axis and leads to downregulation of c-Myc and thereby PKM2 expression, which resulted in reduced aerobic glycolysis, proliferation and chemotherapeutic resistance of HNC cells. Moreover, the c-Myc complementation rescued PAK2 depletion effects and restored aerobic glycolysis, proliferation, migration and invasion in PAK2-depleted cells. The global transcriptome analysis of PAK2-depleted HNC cells revealed the downregulation of various genes involved in active cell proliferation, which indicates that PAK2 overexpression is critical for HNC progression. Together, these results suggest that the axis of PAK2\u2013c-Myc\u2013PKM2 is critical for HNC progression and could be a therapeutic target to reduce the cell proliferation and acquired chemoresistance and might enhance the efficacy of standard chemotherapy which will help in better management of HNC patients.<\/jats:p>","DOI":"10.1038\/s41419-018-0887-0","type":"journal-article","created":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T08:15:28Z","timestamp":1533111328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["PAK2\u2013c-Myc\u2013PKM2 axis plays an essential role in head and neck oncogenesis via regulating Warburg effect"],"prefix":"10.1038","volume":"9","author":[{"given":"Amit","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athira","family":"Ajith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smriti","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra Kumar","family":"Panday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Samaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3361-0588","authenticated-orcid":false,"given":"Sanjeev","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,1]]},"reference":[{"key":"887_CR1","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.tripleo.2005.07.038","volume":"102","author":"J Massano","year":"2006","unstructured":"Massano, J., Regateiro, F. S., Januario, G. & Ferreira, A. Oral squamous cell carcinoma: review of prognostic and predictive factors. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 102, 67\u201376 (2006).","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"887_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrc2982","volume":"11","author":"CR Leemans","year":"2011","unstructured":"Leemans, C. R., Braakhuis, B. J. & Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat. Rev. Cancer 11, 9\u201322 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"887_CR3","doi-asserted-by":"publisher","first-page":"4550","DOI":"10.1200\/JCO.2013.50.3870","volume":"31","author":"AK Chaturvedi","year":"2013","unstructured":"Chaturvedi, A. K. et al. Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J. Clin. Oncol. 31, 4550\u20134559 (2013).","journal-title":"J. Clin. Oncol."},{"key":"887_CR4","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/sj.bdj.2017.293","volume":"222","author":"B Gupta","year":"2017","unstructured":"Gupta, B. & Johnson, N. W. Oral cancer: Indian pandemic.Br. Dent. J. 222, 497 (2017).","journal-title":"Br. Dent. J."},{"key":"887_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal, A. et al. Global cancer statistics. CA Cancer J. Clin. 61, 69\u201390 (2011).","journal-title":"CA Cancer J. Clin."},{"key":"887_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.otohns.2007.04.011","volume":"137","author":"RB Smith","year":"2007","unstructured":"Smith, R. B., Sniezek, J. C., Weed, D. T. & Wax, M. K. Utilization of free tissue transfer in head and neck surgery. Otolaryngol. Head Neck Surg. 137, 182\u2013191 (2007).","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"887_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijrobp.2008.07.059","volume":"74","author":"MR Vergeer","year":"2009","unstructured":"Vergeer, M. R. et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int. J. Radiat. Oncol. Biol. Phys. 74, 1\u20138 (2009).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"887_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/MOO.0b013e3283293631","volume":"17","author":"MA Kuriakose","year":"2009","unstructured":"Kuriakose, M. A. & Trivedi, N. P. Sentinel node biopsy in head and neck squamous cell carcinoma. Curr. Opin. Otolaryngol. Head Neck Surg. 17, 100\u2013110 (2009).","journal-title":"Curr. Opin. Otolaryngol. Head Neck Surg."},{"key":"887_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.canlet.2015.07.022","volume":"367","author":"SP Narayanan","year":"2015","unstructured":"Narayanan, S. P. et al. Integrated genomic analyses identify KDM1A\u2019s role in cell proliferation via modulating E2F signaling activity and associate with poor clinical outcome in oral cancer.Cancer Lett. 367, 162\u2013172 (2015).","journal-title":"Cancer Lett."},{"key":"887_CR10","doi-asserted-by":"publisher","first-page":"5400","DOI":"10.1038\/sj.onc.1205651","volume":"21","author":"M Ehrlich","year":"2002","unstructured":"Ehrlich, M. DNA methylation in cancer: too much, but also too little. Oncogene 21, 5400\u20135413 (2002).","journal-title":"Oncogene"},{"key":"887_CR11","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrc2876","volume":"10","author":"P Chi","year":"2010","unstructured":"Chi, P., Allis, C. D. & Wang, G. G. Covalent histone modifications\u2013miswritten, misinterpreted and mis-erased in human cancers. Nat. Rev. Cancer 10, 457\u2013469 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"887_CR12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrg816","volume":"3","author":"PA Jones","year":"2002","unstructured":"Jones, P. A. & Baylin, S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3, 415\u2013428 (2002).","journal-title":"Nat. Rev. Genet."},{"key":"887_CR13","doi-asserted-by":"publisher","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","volume":"69","author":"SE Elsheikh","year":"2009","unstructured":"Elsheikh, S. E. et al. Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 69, 3802\u20133809 (2009).","journal-title":"Cancer Res."},{"key":"887_CR14","doi-asserted-by":"publisher","first-page":"8206","DOI":"10.18632\/oncotarget.23654","volume":"9","author":"A Al Emran","year":"2018","unstructured":"Al Emran, A. et al. Distinct histone modifications denote early stress-induced drug tolerance in cancer. Oncotarget 9, 8206\u20138222 (2018).","journal-title":"Oncotarget"},{"key":"887_CR15","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1038\/nature03672","volume":"435","author":"DB Seligson","year":"2005","unstructured":"Seligson, D. B. et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 435, 1262\u20131266 (2005).","journal-title":"Nature"},{"key":"887_CR16","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1200\/JCO.2009.24.5639","volume":"28","author":"A Manuyakorn","year":"2010","unstructured":"Manuyakorn, A. et al. Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. J. Clin. Oncol. 28, 1358\u20131365 (2010).","journal-title":"J. Clin. Oncol."},{"issue":"Suppl.","key":"887_CR17","first-page":"R31","volume":"96","author":"SB Hake","year":"2007","unstructured":"Hake, S. B., Xiao, A. & Allis, C. D. Linking the epigenetic \u2018language\u2019 of covalent histone modifications to cancer. Br. J. Cancer 96(Suppl.), R31\u2013R39 (2007).","journal-title":"Br. J. Cancer"},{"key":"887_CR18","first-page":"769","volume":"18","author":"M Nakagawa","year":"2007","unstructured":"Nakagawa, M. et al. Expression profile of class I histone deacetylases in human cancer tissues. Oncol. Rep. 18, 769\u2013774 (2007).","journal-title":"Oncol. Rep."},{"key":"887_CR19","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1002\/ijc.11403","volume":"107","author":"H Kawai","year":"2003","unstructured":"Kawai, H., Li, H., Avraham, S., Jiang, S. & Avraham, H. K. Overexpression of histone deacetylase HDAC1 modulates breast cancer progression by negative regulation of estrogen receptor alpha. Int. J. Cancer 107, 353\u2013358 (2003).","journal-title":"Int. J. Cancer"},{"key":"887_CR20","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/nature01075","volume":"419","author":"S Varambally","year":"2002","unstructured":"Varambally, S. et al. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature 419, 624\u2013629 (2002).","journal-title":"Nature"},{"key":"887_CR21","doi-asserted-by":"publisher","first-page":"D337","DOI":"10.1093\/nar\/gkr1125","volume":"40","author":"SP Khare","year":"2012","unstructured":"Khare, S. P. et al. HIstome\u2013a relational knowledgebase of human histone proteins and histone modifying enzymes. Nucleic Acids Res. 40, D337\u2013D342 (2012).","journal-title":"Nucleic Acids Res."},{"key":"887_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/367040a0","volume":"367","author":"E Manser","year":"1994","unstructured":"Manser, E., Leung, T., Salihuddin, H., Zhao, Z. S. & Lim, L. A brain serine\/threonine protein kinase activated by Cdc42 and Rac1. Nature 367, 40\u201346 (1994).","journal-title":"Nature"},{"key":"887_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/nrc1892","volume":"6","author":"R Kumar","year":"2006","unstructured":"Kumar, R., Gururaj, A. E. & Barnes, C. J. p21-activated kinases in cancer. Nat. Rev. Cancer 6, 459\u2013471 (2006).","journal-title":"Nat. Rev. Cancer"},{"key":"887_CR24","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1038\/onc.2009.119","volume":"28","author":"PR Molli","year":"2009","unstructured":"Molli, P. R., Li, D. Q., Murray, B. W., Rayala, S. K. & Kumar, R. PAK signaling in oncogenesis. Oncogene 28, 2545\u20132555 (2009).","journal-title":"Oncogene"},{"key":"887_CR25","doi-asserted-by":"publisher","first-page":"849","DOI":"10.2741\/3724","volume":"16","author":"A Whale","year":"2011","unstructured":"Whale, A., Hashim, F. N., Fram, S., Jones, G. E. & Wells, C. M. Signalling to cancer cell invasion through PAK family kinases. Front. Biosci. (Landmark Ed.) 16, 849\u2013864 (2011).","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"887_CR26","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1101\/gad.2055511","volume":"25","author":"B Kang","year":"2011","unstructured":"Kang, B. et al. Phosphorylation of H4 Ser 47 promotes HIRA-mediated nucleosome assembly. Genes Dev. 25, 1359\u20131364 (2011).","journal-title":"Genes Dev."},{"key":"887_CR27","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ajh.24970","volume":"93","author":"M Gavillet","year":"2018","unstructured":"Gavillet, M., Martinod, K., Renella, R., Wagner, D. D. & Williams, D. A. A key role for Rac and Pak signaling in neutrophil extracellular traps (NETs) formation defines a new potential therapeutic target. Am. J. Hematol. 93, 269\u2013276 (2018).","journal-title":"Am. J. Hematol."},{"key":"887_CR28","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1093\/nar\/gkt583","volume":"41","author":"H Zhang","year":"2013","unstructured":"Zhang, H., Wang, Z. & Zhang, Z. PP1alpha, PP1beta and Wip-1 regulate H4S47 phosphorylation and deposition of histone H3 variant H3.3. Nucleic Acids Res. 41, 8085\u20138093 (2013).","journal-title":"Nucleic Acids Res."},{"key":"887_CR29","first-page":"3387","volume":"8","author":"WW Deng","year":"2016","unstructured":"Deng, W. W. et al. PAK2 promotes migration and proliferation of salivary gland adenoid cystic carcinoma. Am. J. Transl. Res. 8, 3387\u20133397 (2016).","journal-title":"Am. J. Transl. Res."},{"key":"887_CR30","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/ijc.25005","volume":"127","author":"MK Siu","year":"2010","unstructured":"Siu, M. K. et al. Differential expression and phosphorylation of Pak1 and Pak2 in ovarian cancer: effects on prognosis and cell invasion. Int. J. Cancer 127, 21\u201331 (2010).","journal-title":"Int. J. Cancer"},{"key":"887_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1746-1596-9-55","volume":"9","author":"C Gao","year":"2014","unstructured":"Gao, C., Ma, T., Pang, L. & Xie, R. Activation of P21-activated protein kinase 2 is an independent prognostic predictor for patients with gastric cancer. Diagn. Pathol. 9, 55 (2014).","journal-title":"Diagn. Pathol."},{"key":"887_CR32","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."},{"key":"887_CR33","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2013update. Nucleic Acids Res. 41, D991\u2013D995 (2013).","journal-title":"Nucleic Acids Res."},{"key":"887_CR34","doi-asserted-by":"publisher","first-page":"e3078","DOI":"10.1038\/cddis.2017.461","volume":"8","author":"P Kumari","year":"2017","unstructured":"Kumari, P. et al. Essential role of HCMV deubiquitinase in promoting oncogenesis by targeting anti-viral innate immune signaling pathways. Cell Death Dis. 8, e3078 (2017).","journal-title":"Cell Death Dis."},{"key":"887_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"887_CR36","doi-asserted-by":"publisher","first-page":"11440","DOI":"10.1073\/pnas.1708447114","volume":"114","author":"S Singh","year":"2017","unstructured":"Singh, S. et al. Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect. Proc. Natl Acad. Sci. USA 114, 11440\u201311445 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"887_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes, D. R. et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6, 1\u20136 (2004).","journal-title":"Neoplasia"},{"key":"887_CR38","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1158\/0008-5472.CAN-05-4399","volume":"66","author":"S Sengupta","year":"2006","unstructured":"Sengupta, S. et al. Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma. Cancer Res. 66, 7999\u20138006 (2006).","journal-title":"Cancer Res."},{"key":"887_CR39","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1038\/sj.onc.1207345","volume":"23","author":"A Cromer","year":"2004","unstructured":"Cromer, A. et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 23, 2484\u20132498 (2004).","journal-title":"Oncogene"},{"key":"887_CR40","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cancergencyto.2004.01.026","volume":"154","author":"GA Toruner","year":"2004","unstructured":"Toruner, G. A. et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet. Cytogenet. 154, 27\u201335 (2004).","journal-title":"Cancer Genet. Cytogenet."},{"key":"887_CR41","doi-asserted-by":"publisher","first-page":"3463","DOI":"10.1128\/MCB.15.7.3463","volume":"15","author":"D Resnitzky","year":"1995","unstructured":"Resnitzky, D. & Reed, S. I. Different roles for cyclins D1 and E in regulation of the G1-to-S transition. Mol. Cell Biol. 15, 3463\u20133469 (1995).","journal-title":"Mol. Cell Biol."},{"key":"887_CR42","first-page":"pii: 2573","volume":"49","author":"H Rafehi","year":"2011","unstructured":"Rafehi, H. et al. Clonogenic assay: adherent cells. J. Vis. Exp. 49, pii: 2573 (2011).","journal-title":"J. Vis. Exp."},{"key":"887_CR43","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"887_CR44","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/nature11005","volume":"483","author":"MJ Garnett","year":"2012","unstructured":"Garnett, M. J. et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483, 570\u2013575 (2012).","journal-title":"Nature"},{"key":"887_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1593\/neo.81446","volume":"11","author":"JW Marlin","year":"2009","unstructured":"Marlin, J. W., Eaton, A., Montano, G. T., Chang, Y. W. & Jakobi, R. Elevated p21-activated kinase 2 activity results in anchorage-independent growth and resistance to anticancer drug-induced cell death. Neoplasia 11, 286\u2013297 (2009).","journal-title":"Neoplasia"},{"key":"887_CR46","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.cell.2008.01.052","volume":"133","author":"X Wu","year":"2008","unstructured":"Wu, X. et al. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 133, 340\u2013353 (2008).","journal-title":"Cell"},{"key":"887_CR47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1593\/neo.111060","volume":"13","author":"L Zhou","year":"2011","unstructured":"Zhou, L. et al. Merlin-deficient human tumors show loss of contact inhibition and activation of Wnt\/beta-catenin signaling linked to the PDGFR\/Src and Rac\/PAK pathways. Neoplasia 13, 1101\u20131112 (2011).","journal-title":"Neoplasia"},{"key":"887_CR48","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0092-8674(02)01014-0","volume":"111","author":"M van de Wetering","year":"2002","unstructured":"van de Wetering, M. et al. The beta-catenin\/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111, 241\u2013250 (2002).","journal-title":"Cell"},{"key":"887_CR49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.3332\/ecancer.2009.128","volume":"3","author":"R Pai","year":"2009","unstructured":"Pai, R. et al. Over-expression of c-Myc oncoprotein in oral squamous cell carcinoma in the South Indian population. Ecancermedicalscience 3, 128 (2009).","journal-title":"Ecancermedicalscience"},{"key":"887_CR50","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1158\/0008-5472.CAN-10-3776","volume":"71","author":"A Wolfer","year":"2011","unstructured":"Wolfer, A. & Ramaswamy, S. MYC and metastasis. Cancer Res. 71, 2034\u20132037 (2011).","journal-title":"Cancer Res."},{"key":"887_CR51","doi-asserted-by":"publisher","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","volume":"18","author":"DM Miller","year":"2012","unstructured":"Miller, D. M., Thomas, S. D., Islam, A., Muench, D. & Sedoris, K. c-Myc and cancer metabolism. Clin. Cancer Res. 18, 5546\u20135553 (2012).","journal-title":"Clin. Cancer Res."},{"key":"887_CR52","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer, G. & Pouyssegur, J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel.Cancer Cell 13, 472\u2013482 (2008).","journal-title":"Cancer Cell"},{"key":"887_CR53","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033 (2009).","journal-title":"Science"},{"key":"887_CR54","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/carcin\/bgp220","volume":"31","author":"S Sharma","year":"2010","unstructured":"Sharma, S., Kelly, T. K. & Jones, P. A. Epigenetics in cancer. Carcinogenesis 31, 27\u201336 (2010).","journal-title":"Carcinogenesis"},{"key":"887_CR55","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00432-017-2561-9","volume":"144","author":"C Lv","year":"2018","unstructured":"Lv, C. et al. The function of BTG3 in colorectal cancer cells and its possible signaling pathway. J. Cancer Res. Clin. Oncol. 144, 295\u2013308 (2018).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"887_CR56","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1093\/carcin\/bgq271","volume":"32","author":"T Li","year":"2011","unstructured":"Li, T. et al. P21-activated protein kinase (PAK2)-mediated c-Jun phosphorylation at 5 threonine sites promotes cell transformation. Carcinogenesis 32, 659\u2013666 (2011).","journal-title":"Carcinogenesis"},{"key":"887_CR57","doi-asserted-by":"crossref","first-page":"19709","DOI":"10.18632\/oncotarget.7573","volume":"7","author":"SK Gopal","year":"2016","unstructured":"Gopal, S. K. et al. Oncogenic epithelial cell-derived exosomes containing Rac1 and PAK2 induce angiogenesis in recipient endothelial cells. Oncotarget 7, 19709\u201319722 (2016).","journal-title":"Oncotarget"},{"key":"887_CR58","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/bjh.14833","volume":"179","author":"L Edlinger","year":"2017","unstructured":"Edlinger, L. et al. Expansion of BCR\/ABL1(+) cells requires PAK2 but not PAK1. Br. J. Haematol. 179, 229\u2013241 (2017).","journal-title":"Br. J. Haematol."},{"key":"887_CR59","doi-asserted-by":"crossref","first-page":"44171","DOI":"10.18632\/oncotarget.17396","volume":"8","author":"WQ Lu","year":"2017","unstructured":"Lu, W. Q., Hu, Y. Y., Lin, X. P. & Fan, W. Knockdown of PKM2 and GLS1 expression can significantly reverse oxaliplatin-resistance in colorectal cancer cells. Oncotarget 8, 44171\u201344185 (2017).","journal-title":"Oncotarget"},{"key":"887_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/srep45983","volume":"7","author":"X Wang","year":"2017","unstructured":"Wang, X., Zhang, F. & Wu, X. R. Inhibition of pyruvate kinase M2 markedly reduces chemoresistance of advanced bladder cancer to cisplatin. Sci. Rep. 7, 45983 (2017).","journal-title":"Sci. Rep."},{"key":"887_CR61","doi-asserted-by":"publisher","first-page":"8260","DOI":"10.1038\/sj.onc.1208007","volume":"23","author":"S Esufali","year":"2004","unstructured":"Esufali, S. & Bapat, B. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF\/LEF-mediated transcriptional activation. Oncogene 23, 8260\u20138271 (2004).","journal-title":"Oncogene"},{"key":"887_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pharmthera.2015.10.009","volume":"156","author":"M Masuda","year":"2015","unstructured":"Masuda, M., Sawa, M., & Yamada, T. Therapeutic targets in the Wnt signaling pathway: feasibility of targeting TNIK in colorectal cancer. Pharmacol. Ther. 156, 1\u20139 (2015).","journal-title":"Pharmacol. Ther."},{"key":"887_CR63","doi-asserted-by":"publisher","first-page":"e0192009","DOI":"10.1371\/journal.pone.0192009","volume":"13","author":"J Chuerduangphui","year":"2018","unstructured":"Chuerduangphui, J. et al. Effects of arecoline on proliferation of oral squamous cell carcinoma cells by dysregulating c-Myc and miR-22, directly targeting oncostatin M. PLoS ONE 13, e0192009 (2018).","journal-title":"PLoS One"},{"key":"887_CR64","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1101\/gad.1024602","volume":"16","author":"TA Baudino","year":"2002","unstructured":"Baudino, T. A. et al. c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev. 16, 2530\u20132543 (2002).","journal-title":"Genes Dev."},{"key":"887_CR65","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1002\/jcb.26718","volume":"119","author":"P Aswini","year":"2018","unstructured":"Aswini, P, Grace Raji, R., Haritha, K, Lincy, E. & Sameer Kumar, V. ER stress mediated regulation of miR23a confer Hela cells better adaptability to utilize glycolytic pathway. J. Cell Biochem. 119, 4907\u20134917 (2018).","journal-title":"J. Cell Biochem."},{"key":"887_CR66","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/cdd.2016.151","volume":"24","author":"EJ Kim","year":"2017","unstructured":"Kim, E. J., Kim, S. H., Jin, X. & Kim, H. KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc. Cell Death Differ. 24, 649\u2013659 (2017).","journal-title":"Cell Death Differ."},{"key":"887_CR67","doi-asserted-by":"publisher","first-page":"5923","DOI":"10.1128\/MCB.24.13.5923-5936.2004","volume":"24","author":"JW Kim","year":"2004","unstructured":"Kim, J. W. et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays.Mol. Cell Biol. 24, 5923\u20135936 (2004).","journal-title":"Mol. Cell Biol."},{"key":"887_CR68","doi-asserted-by":"publisher","first-page":"4355","DOI":"10.1158\/0008-5472.CAN-17-0498","volume":"77","author":"A Mendez-Lucas","year":"2017","unstructured":"Mendez-Lucas, A. et al. Glucose catabolism in liver tumors induced by c-MYC can be sustained by various PKM1\/PKM2 ratios and pyruvate kinase activities. Cancer Res. 77, 4355\u20134364 (2017).","journal-title":"Cancer Res."},{"key":"887_CR69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nature06667","volume":"452","author":"HR Christofk","year":"2008","unstructured":"Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M. & Cantley, L. C. Pyruvate kinase M2 is a phosphotyrosine-binding protein. Nature 452, 181\u2013186 (2008).","journal-title":"Nature"},{"key":"887_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.molcel.2013.11.001","volume":"53","author":"Y Jiang","year":"2014","unstructured":"Jiang, Y. et al. PKM2 regulates chromosome segregation and mitosis progression of tumor cells. Mol. Cell 53, 75\u201387 (2014).","journal-title":"Mol. Cell"},{"key":"887_CR71","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.4161\/cc.26182","volume":"12","author":"W Yang","year":"2013","unstructured":"Yang, W. & Lu, Z. Nuclear PKM2 regulates the Warburg effect. Cell Cycle 12, 3154\u20133158 (2013).","journal-title":"Cell Cycle"},{"key":"887_CR72","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jhep.2011.01.038","volume":"55","author":"K Kitamura","year":"2011","unstructured":"Kitamura, K. et al. Proliferative activity in hepatocellular carcinoma is closely correlated with glucose metabolism but not angiogenesis. J. Hepatol. 55, 846\u2013857 (2011).","journal-title":"J. Hepatol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0887-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0887-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T07:17:37Z","timestamp":1671520657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0887-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,1]]},"references-count":72,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,8]]}},"alternative-id":["887"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0887-0","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,1]]},"assertion":[{"value":"2 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"825"}}